Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients

This study has been completed.

Sponsor:

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Information provided by:

Washington University School of Medicine

ClinicalTrials.gov Identifier:

NCT01113099

First received: April 22, 2010

Last updated: April 27, 2010

Last verified: April 2010

History of Changes

Purpose

We hypothesize that when compared to usual care a greater proportion of hospitalized diabetic patients who are candidates for cholesterol lowering will be discharged with a prescription for a statin if their physicians are contacted by a pharmacist to discuss treatment guidelines.

Condition	Intervention
Diabetes Dyslipidemia	Other: Academic detailing

Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research
Official Title:	Assisted Detailing to Improve Guideline Adherence

Resource links provided by NLM:

MedlinePlus related topics: Cholesterol Statins

U.S. FDA Resources

Further study details as provided by Washington University School of Medicine:

Primary Outcome Measures:

Statin prescription at hospital discharge [ Time Frame: Hospital discharge (avg = 3 days) ] [ Designated as safety issue: No ]

Enrollment:	247
Study Start Date:	June 2006
Study Completion Date:	June 2007
Primary Completion Date:	June 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Academic detailing of physicians	Other: Academic detailing Education of physicians by pharmacists regarding indications for statins in diabetic patients
No Intervention: Usual care

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Hospitalized patients with diabetes
LDL >= 100

Exclusion Criteria:

Terminal illness
Pregnancy
Intolerance or contraindication to statin

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01113099

Locations

United States, Missouri
Barnes Jewish Hospital
St. Louis, Missouri, United States, 63110

Sponsors and Collaborators

Washington University School of Medicine

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Principal Investigator:

Thomas C Bailey, MD

Washington University School of Medicine

More Information

Publications:

McKinnon PS, Seaton T, Noirot LA, Reichley RM, Heard KM, Shannon WD, Goldberg AC, Dunagan WC, Bailey TC. Improving adherence to dyslipidemia medication guidelines in hospitalized diabetic patients using a technology-assisted pharmacist intervention. AMIA Annu Symp Proc. 2008 Nov 6;:868.

Reichley R, McKinnon PS, Seaton T, Noirot L, Dunagan WC, Bailey TC. Adherence to dyslipidemia treatment guidelines in diabetic patients. AMIA Annu Symp Proc. 2006;:1071.

Reichley R, Rachmiel E, Seaton T, Noirot L, Longyhore D, Dunagan WC, Bailey TC. Intervention to improve dyslipidemia screening in hospitalized diabetics. AMIA Annu Symp Proc. 2005;:1093.

McKinnon PS, Reichley RM, Noirot LA, Dunagan WC, Bailey TC. Prospective validation of an algorithm to identify hospitalized diabetic patients using administrative data. AMIA Annu Symp Proc. 2006;:1029.

Responsible Party:	Thomas C Bailey/Professor of Medicine, Washington University School of Medicine
ClinicalTrials.gov Identifier:	NCT01113099 History of Changes
Other Study ID Numbers:	02-1072, R01HL070790
Study First Received:	April 22, 2010
Last Updated:	April 27, 2010
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on May 22, 2013

To Top